Back to Search Start Over

MiR-204 regulates type 1 IP3R to control vascular smooth muscle cell contractility and blood pressure.

Authors :
Gabani, Mohanad
Liu, Jing
Ait-Aissa, Karima
Koval, Olha
Kim, Young-Rae
Castañeda, Diana
Vikram, Ajit
Jacobs, Julia S.
Grumbach, Isabella
Trebak, Mohamed
Irani, Kaikobad
Kassan, Modar
Source :
Cell Calcium; Jun2019, Vol. 80, p18-24, 7p
Publication Year :
2019

Abstract

• miR-204 selectively target IP3R1in vascular smooth muscle cells. • miR-204 regulates calcium release from the endoplasmic reticulum. • miR-204 controls vascular smooth muscle cells contractility. • miR-204 plays an important role in regulating blood pressure. MiR-204 is expressed in vascular smooth muscle cells (VSMC). However, its role in VSMC contraction is not known. We determined if miR-204 controls VSMC contractility and blood pressure through regulation of sarcoplasmic reticulum (SR) calcium (Ca<superscript>2+</superscript>) release. Systolic blood pressure (SBP) and vasoreactivity to VSMC contractile agonists (phenylephrine (PE), thromboxane analogue (U46619), endothelin-1 (ET-1), angiotensin-II (Ang II) and norepinephrine (NE) were compared in aortas and mesenteric resistance arteries (MRA) from miR-204<superscript>−/−</superscript> mice and wildtype mice (WT). There was no difference in basal systolic blood pressure (SBP) between the two genotypes; however, hypertensive response to Ang II was significantly greater in miR-204<superscript>−/−</superscript> mice compared to WT mice. Aortas and MRA of miR-204<superscript>−/−</superscript> mice had heightened contractility to all VSMC agonists. In silico algorithms predicted the type 1 Inositol 1, 4, 5-trisphosphate receptor (IP 3 R1) as a target of miR-204. Aortas and MRA of miR-204<superscript>−/−</superscript> mice had higher expression of IP 3 R1 compared to WT mice. Difference in agonist-induced vasoconstriction between miR-204<superscript>−/−</superscript> and WT mice was abolished with pharmacologic inhibition of IP 3 R1. Furthermore, Ang II-induced aortic IP 3 R1 was greater in miR-204<superscript>−/−</superscript> mice compared to WT mice. In addition, difference in aortic vasoconstriction to VSMC agonists between miR-204<superscript>−/−</superscript> and WT mice persisted after Ang II infusion. Inhibition of miR-204 in VSMC in vitro increased IP 3 R1, and boosted SR Ca<superscript>2+</superscript> release in response to PE, while overexpression of miR-204 downregulated IP 3 R1. Finally, a sequence-specific nucleotide blocker that targets the miR-204-IP 3 R1 interaction rescued miR-204-induced downregulation of IP 3 R1. We conclude that miR-204 controls VSMC contractility and blood pressure through IP 3 R1-dependent regulation of SR calcium release. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01434160
Volume :
80
Database :
Supplemental Index
Journal :
Cell Calcium
Publication Type :
Academic Journal
Accession number :
136692433
Full Text :
https://doi.org/10.1016/j.ceca.2019.03.006